Larvol Delta - Efficacy-and-Safety-of-AbGn168H-in-Patients-With-Moderate-to-Severe-Active-AntiTNF-Alpha-andor-Antiintegrin-Refractory-Ulcerative-Colitis

neihulizumab (AbGn-168H) - AbGenomics

http://clinicaltrials.gov/ct2/show/NCT03298022

Aug 17, 2020

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next